EyePoint Pharmaceuticals’ (EYPT) Buy Rating Reaffirmed at HC Wainwright
HC Wainwright reiterated their buy rating on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research note released on Thursday morning,Benzinga reports. The firm currently has a $22.00 price objective on the stock. EYPT has been the subject of a number of other reports. Mizuho dropped their target price on shares of EyePoint […]
HC Wainwright reiterated their buy rating on shares of EyePoint Pharmaceuticals (NASDAQ:EYPT – Free Report) in a research note released on Thursday morning,Benzinga reports. The firm currently has a $22.00 price objective on the stock. EYPT has been the subject of a number of other reports. Mizuho dropped their target price on shares of EyePoint […]
